Prestige Wealth Management Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Prestige Wealth Management Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90	Closed	-$1K	–	1053
2022 Q1	$1K	Hold	90	–	–	﹤0.01%	919
2021 Q4	$1K	Hold	90	–	–	﹤0.01%	940
2021 Q3	$1K	Hold	90	–	–	﹤0.01%	928
2021 Q2	$1K	Hold	90	–	–	﹤0.01%	918
2021 Q1	$1K	Hold	90	–	–	﹤0.01%	905
2020 Q4	$1K	Sell	90 -230	-72%	-$3.1K	﹤0.01%	881
2020 Q3	$4K	Hold	320	–	–	﹤0.01%	587
2020 Q2	$3K	Sell	320 -85	-21%	-$865	﹤0.01%	629
2020 Q1	$3K	Buy	405 +375	+1,250%	+$3.13K	﹤0.01%	589
2019 Q4	$0	Buy	+30	New	+$237	﹤0.01%	650
2019 Q1	–	Sell	-1,105	Closed	-$8K	–	984
2018 Q4	$8K	Buy	+1,105	New	+$7.77K	0.01%	485

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Prestige Wealth Management Group's RDY Position: Q2 2022 in Review

Prestige Wealth Management Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2022, closing a stake of 90 shares — an estimated $1K sold.

Prestige Wealth Management Group first reported a position in RDY in Q4 2018 and held it in 11 quarters. The position peaked at $8K in Q4 2018. 148 funds tracked by Wall St. Rank hold RDY as of Q2 2022.

Prestige Wealth Management Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2022 after selling out during the quarter.
Prestige Wealth Management Group sold 90 Dr. Reddy's Laboratories shares in Q2 2022, an estimated $1K.
Prestige Wealth Management Group first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 11 quarters.
Prestige Wealth Management Group's Dr. Reddy's Laboratories position peaked at $8K in Q4 2018.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2022.

Based on Prestige Wealth Management Group's 13F filing for Q2 2022, filed 10 Aug 2022.